NCT04490512View on ClinicalTrials.gov

Study of FluBHPVE6E7 in HPV-16 Infected Women

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

December 9, 2020

Primary Completion Date

March 16, 2023

Study Completion Date

June 6, 2023

Conditions
HPV Infection
Interventions
BIOLOGICAL

FluBHPVE6E7

Multiple subcutaneous, intradermal or intramuscular administrations

Trial Locations (1)

1090

Medical University of Vienna, Vienna

Sponsors
All Listed Sponsors
lead

BlueSky Immunotherapies GmbH

INDUSTRY